CoreCap Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
CoreCap Advisors's AMGN Position: Q2 2026 in Review
CoreCap Advisors reduced its Amgen (AMGN) stake by 18% in Q2 2026, selling an estimated $431K and leaving 5,755 shares worth $2.08M. The position accounts for 0.06% of the portfolio, ranked #247.
CoreCap Advisors first reported a position in AMGN in Q4 2021 and has held it in 17 quarters since. The position peaked at $3.88M in Q4 2023. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- CoreCap Advisors held 5,755 shares of Amgen worth $2.08M as of Q2 2026.
- CoreCap Advisors sold 1,258 Amgen shares in Q2 2026, an estimated $431K.
- Amgen made up 0.06% of CoreCap Advisors's portfolio in Q2 2026, its #247 holding.
- CoreCap Advisors first reported a position in Amgen in Q4 2021 and has held it in 17 quarters since.
- CoreCap Advisors's Amgen position peaked at $3.88M in Q4 2023.
- 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.